???global.info.a_carregar???
Susana Bandarra. Concluiu o(a) Mestrado em Controlo de Qualidade e Toxicologia dos Alimentos em 2011/02 pelo(a) Universidade de Lisboa Faculdade de Farmácia e Licenciatura em Química Aplicada em 2005 pelo(a) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia. Frequenta o(a) Doutoramento em Farmácia pelo(a) Universidade de Lisboa Faculdade de Farmácia. É Investigador no(a) Centro de Investigação Interdisciplinar Egas Moniz. Publicou 15 artigos em revistas especializadas. Participa e/ou participou como Bolseiro de Investigação em 1 projeto(s). Nas suas atividades profissionais interagiu com 62 colaborador(es) em coautorias de trabalhos científicos. No seu currículo Ciência Vitae os termos mais frequentes na contextualização da produção científica, tecnológica e artístico-cultural são: Hyperglycemia phenotype; Salivary glucose biomarker; HIV-1; HIV-2; APOBEC3; Acrilamida; Glicidamida; Células mamárias MCF10A; Citotoxicidade; Genotoxicidade; Teses de Mestrado - 2010; .
Read full resume ↓
Identification

Personal identification

Full name
Susana Bandarra

Citation names

  • Bandarra, Susana

Author identifiers

Ciência ID
5411-B5EA-8C71
ORCID iD
0000-0001-9226-6997
Researcher Id
T-5158-2018

Email addresses

  • sbandarra@egasmoniz.edu.pt (Professional)

Telephones

Telephone
  • 212946700 Ext.: 6761 (Professional)

Addresses

  • Centro de Investigação Interdisciplinar Egas Moniz. Instituto Universitário Egas Moniz, Quinta da Granja, Monte de Caparica, 2829 - 511, Caparica, Almada, Portugal (Professional)

Websites

Education
Degree Classification
2019
Ongoing
 Farmácia (Doutoramento)
Major in Especialidade: Biotecnologia Farmacêutica
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Caracterização do efeito da família APOBEC3 na infecção por HIV-2: Contributo para o desenvolvimento de novas terapêuticas" (THESIS/DISSERTATION)
2008/10 - 2011/02
Concluded
 Controlo de Qualidade e Toxicologia dos Alimentos (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Avaliação da citotoxicidade e genotoxicidade da glicidamida em células mamárias humanas." (THESIS/DISSERTATION)
 18 valores
1999 - 2005
Concluded
 Química Aplicada (Licenciatura)
Major in Biotecnologia
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
"Detecção de potenciais parceiros celulares da proteína Prickle(galinha) - rastreio de um banco de cDNA pela técnica do duplo híbrido" (THESIS/DISSERTATION)
 15 valores
Affiliation

Science

Category
Host institution 		Employer
2016/09/01 - 2019/09/01 Contracted Researcher (Research) Centro de Investigação Interdisciplinar Egas Moniz, Portugal
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2020/02/01 - Current Invited Assistant (University Teacher) Escola Superior de Saúde Egas Moniz, Portugal
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal
2005/10/01 - 2013/09/30 Invited Assistant (University Teacher) Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
2010/04/01 - 2011/09/30 Assistant (Polytechnic Teacher) Escola Superior de Saúde Ribeiro Sanches, Portugal
2007/05/01 - 2008/06/30 Assistant (Polytechnic Teacher) Escola Superior de Saúde Egas Moniz, Portugal
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal

Others

Category
Host institution 		Employer
2020/03/27 - Current Diagnóstico em Biologia Molecular (Covid19) SYNLAB PORTUGAL, Portugal
SYNLAB PORTUGAL, Portugal
2019/11 - 2019/12 Participation in the visiting program of the National Institutes of Health (NIH) to consult with associates in the field and to do some work with Dr. Klaus Centro de Investigação Interdisciplinar Egas Moniz, Portugal
2012/04/01 - 2016/07/31 PhD fellowship (SFRH/BD/81291/2011) Fundação para a Ciência e a Tecnologia, Portugal
2004/07/01 - 2004/09/30 Experiência auto-proposta no âmbito do programa ERASMUS Laboratory of Insect Molecular Genetics and Biotechnology, Institute of Biology, NCSR "Demokritos",Aghia Paraskevi Attikis, Athens, Greece, Greece
Projects

Grant

Designation Funders
2016/02 - 2019/01 Breast cancer therapeutics with Vif
Provided by PTCRIS: 145273
Research Fellow
Centro de Investigação Interdisciplinar Egas Moniz, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
Outputs

Publications

Conference paper
  1. Mascarenhas, Paulo; Bandarra, Susana; Ribeiro, Ana Clara; Barahona, Isabel. "Hyperglycemia phenotype as indicated by salivary glucose biomarker". 2017.
  2. Bandarra, Susana; Ribeiro, Ana Clara; Gonçalves, João; Barahona, Isabel. "Are there infectivity differences between HIV-2 and HIV-1 related to APOBEC3?". 2014.
Journal article
  1. Susana Bandarra; Eri Miyagi; Ana Clara Ribeiro; João Gonçalves; Klaus Strebel; Isabel Barahona; Viviana Simon. "APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner". Journal of Virology (2021): https://doi.org/10.1128/JVI.01170-21.
    10.1128/JVI.01170-21
  2. Susana Bandarra; Lurdes Monteiro; Laura Brum. "Detection of the SARS-CoV-2 UK Variant in Portugal". Medical Sciences Forum 5 1 (2021): 39-39. https://doi.org/10.3390/msf2021005039.
    10.3390/msf2021005039
  3. Adriana Ferraz; Susana Bandarra; Paulo Mascarenhas; Isabel Barahona; Rui Martins; Ana Ribeiro. "Characterization of CYP2C19*17 Polymorphism in a Portuguese Population Sample Relevant for Proton Pump Inhibitor Therapy—A Pilot Study". Medical Sciences Forum 5 1 (2021): 19-19. https://doi.org/10.3390/msf2021005019.
    10.3390/msf2021005019
  4. Sofia Santos; Paulo Mascarenhas; Susana Bandarra; Ana Ribeiro; Paulo Maurício; Isabel Barahona. "Evaluation of the Cytotoxic Potential of Adhesives, with Two on the Market: Scotchbond Universal and Optibond Solo Plus, and an Adhesive in the Experimental Phase: T1". Medical Sciences Forum 5 1 (2021): 7-7. https://doi.org/10.3390/msf2021005007.
    10.3390/msf2021005007
  5. Susana Bandarra; Joana Neves; Ana Paraíso; Paulo Mascarenhas; Ana C. Ribeiro; Isabel Barahona. "Biocompatibility of self-adhesive resin cement with fibroblast cells". The Journal of Prosthetic Dentistry (2021): https://doi.org/10.1016/j.prosdent.2021.01.002.
    10.1016/j.prosdent.2021.01.002
  6. Bandarra, Susana. "Suitability of 3D printed pieces of nanocrystalline zirconia for dental applications". Dental Materials (2020): http://dx.doi.org/10.1016/j.dental.2020.01.006.
    10.1016/j.dental.2020.01.006
  7. Susana Bandarra; Paulo Mascarenhas; Ana R. Luís; Mafalda Catrau; Evguenia Bekman; Ana C. Ribeiro; Sérgio Félix; Jorge Caldeira; Isabel Barahona. "In vitro and in silico evaluations of resin-based dental restorative material toxicity". Clinical Oral Investigations (2019): https://doi.org/10.1007/s00784-019-03131-4.
    10.1007/s00784-019-03131-4
  8. Bandarra, Susana. "Production of breast cancer cell lines expressing viral gene VIF". Annals of Medicine (2019): http://dx.doi.org/10.1080/07853890.2018.1561805.
    10.1080/07853890.2018.1561805
  9. Bandarra, Susana. "Effect of polymerization methods in the cytotoxicity of two resins used in removable prosthodontics – an in vitro study". Annals of Medicine (2019): http://dx.doi.org/10.1080/07853890.2018.1561990.
    10.1080/07853890.2018.1561990
  10. Bandarra, Susana. "Inactivation of APOBEC3G gene in breast cancer cells using the CRISPR/Cas9 system". Annals of Medicine (2019): http://dx.doi.org/10.1080/07853890.2018.1561848.
    10.1080/07853890.2018.1561848
  11. Bandarra, Susana. "Variability in the UDP-glucuronosyltransferase 1A1 (UGT1A1) promotor in a HIV-infected Portuguese population". Annals of Medicine (2019): http://dx.doi.org/10.1080/07853890.2018.1561724.
    10.1080/07853890.2018.1561724
  12. Bandarra, S.; Ribeiro, A. C.; Mascarenhas, P.; Bekman, E.; Barahona, I.. "Characterization of APOBEC3 expression in breast cancer cell lines". Annals of Medicine 50 (2018): S25-S26. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000430497900030&KeyUID=WOS:000430497900030.
  13. Bandarra, S.; Ribeiro, A. C.; Mascarenhas, P.; Bekman, E.; Goncalves, J.; Barahona, I.. "APOBEC3 are host defenses against HIV-2 infections". Annals of Medicine 50 (2018): S42-S43. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000430497900050&KeyUID=WOS:000430497900050.
  14. Neves, J.; Avelar, M.; Bandarra, S.; Ribeiro, A. C.; Mascarenhas, P.; Bekman, E.; Barahona, I.. "Determination of median lethal dose of three bulk-fill resin composites". Annals of Medicine 50 (2018): S59-S60. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000430497900071&KeyUID=WOS:000430497900071.
  15. Mascarenhas, P.; Vagish Kumar, L. S.; Cortelli, J. R.; Cortelli, S. C.; Bandarra, S.; Bekman, E.; Ribeiro, A. C.; Barahona, I.. "Cross-validation and quality assessment of a prediction model based on salivary glucose for early screening of type 2 diabetes mellitus". Annals of Medicine 50 (2018): S112-S113. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000430497900134&KeyUID=WOS:000430497900134.
  16. Ferraz, A.; Fernandes, A.; Cruz, J. P.; Bandarra, S.; Mascarenhas, P.; Bekman, E.; Morais, J. G.; et al. "Pharmacogenetic: characterization of phase I drug-metabolising enzymes polymorphisms in a HIV-infected Portuguese population". Annals of Medicine 50 (2018): S35-S36. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000430497900042&KeyUID=WOS:000430497900042.
  17. Azenha, G.; Fernandes, A.; Cruz, J. P.; Bandarra, S.; Mascarenhas, P.; Bekman, E.; Morais, J. G.; et al. "Frequency of PXR 63396C > T polymorphism in Portuguese HIV-1 infected patients subject to Atazanavir treatment". Annals of Medicine 50 (2018): S43-S44. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000430497900051&KeyUID=WOS:000430497900051.
  18. "Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines.". Forensic science international (2016): http://europepmc.org/abstract/med/27054591.
    10.1016/j.forsciint.2016.03.024
  19. Bandarra, S.; Fernandes, A.S.; Magro, I.; Guerreiro, P.S.; Pingarilho, M.; Churchwell, M.I.; Gil, O.M.; et al. "Erratum: Mechanistic insights into the cytotoxicity and genotoxicity induced by glycidamide in human mammary cells (Mutagenesis (2013) 28:6 (721-729))". Mutagenesis 29 1 (2014): 97-97. http://www.scopus.com/inward/record.url?eid=2-s2.0-84891367154&partnerID=MN8TOARS.
    10.1093/mutage/get059
  20. Bandarra S; Fernandes AS; Magro I; Guerreiro PS; Pingarilho M; Churchwell MI; Gil OM; et al. "Mechanistic insights into the cytotoxicity and genotoxicity induced by glycidamide in human mammary cells.". (2013): http://europepmc.org/abstract/med/24150595.
    10.1093/mutage/get052
Thesis / Dissertation
  1. Bandarra, Susana Isabel Casaca Figueiredo. "Avaliação da citotoxidade e genotoxidade da glicidamida em células mamárias humanas". Master, 2010. http://hdl.handle.net/10451/15308.